NOTCH1 and B-cell chronic lymphocytic leukemia: Patients with unmutated IGHV CLL accounted for 76.9% (10/13), and the most frequent genetic and molecular aberrations included +12 [3/7 (42.9%)], ATM mutation [6/12 (50%)], and NOTCH1 mutation [6/12 (50%)].